Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GDF2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CD40 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SPINK2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | ITGB3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PPP1R9B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CLN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CYTH4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EPN1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |